Industry insights
Lianbang Named a Little Giant in Chengdu’s Fourth Batch
Reported by People's Daily Sichuan
Chengdu Lianbang Medical Technology was named among the biomedical companies in Chengdu’s fourth batch of national “little giant” enterprises. The round added 95 companies — 68.8% of Sichuan’s total for that batch — taking the city’s cumulative count to 202.
Keywords: little giant enterprise, specialised SME, Chengdu, medical oxygen manufacturer
Chengdu Lianbang Medical Technology was named among the biomedical companies in Chengdu’s fourth batch of national “little giant” enterprises, in a report by People’s Daily’s Sichuan channel on 14 October 2022. The batch added 95 Chengdu companies — 68.8% of Sichuan’s total for that round — bringing the city’s cumulative count to 202.
The report grouped Lianbang with Okang Pharmaceutical, Xinhengchuang Pharmaceutical, Yinuodabo Medical Technology, Qingshan Likang Pharmaceutical and Meichuang Medical Technology as the health-sector entrants. The rest of the batch concentrated in electronics and equipment manufacturing, which is the shape of Chengdu’s industrial base.
Why the count matters to a buyer: behind it sits a cultivation system that pays part of the certification, testing and research work export markets demand. It is also why a supplier’s “national little giant” claim has a defined meaning rather than being a marketing phrase.
The three-tier ladder
China’s specialized SME programme has three levels, and companies are expected to climb them in order:
- Innovative SME — the entry tier, for companies with a registered intellectual property base and a defined product niche.
- Provincial specialized SME — the middle tier, judged on specialization, R&D intensity and share of a narrow market segment.
- National “little giant” — the top tier, awarded by the Ministry of Industry and Information Technology to companies that hold a meaningful share of a narrow market and supply a link in a national industrial chain.
Each tier unlocks different support: direct awards, subsidised R&D spending, priority in land and utility allocation, and access to public procurement lists. The ladder is deliberately narrow at the top — the point is not to certify as many companies as possible but to concentrate support on firms that already export or could.
What Chengdu’s cultivation system does
The city’s approach combined three mechanisms. First, a cultivation database: the economics and information bureau screened companies from the statistics of above-scale industrial firms, high-tech enterprises and technology-based SMEs, then assigned each a target tier and a service officer. Second, a growth programme: small firms were pushed to become “above-scale” (annual revenue above RMB 20 million) before being considered for the specialized ladder.
Third, a policy package. Chengdu’s manufacturing policy system — known locally as “1+7” — bundles support for R&D, digital transformation, market access and financing into one framework rather than separate schemes. In practice that matters: a company applying for four unrelated subsidies spends more on paperwork than it receives.
The city’s own measure of success is not only the count of awards. In the Ministry of Industry and Information Technology’s 2021 evaluation of the SME development environment, Chengdu ranked ninth among Chinese cities and first in the central and western regions. That ranking weighs access to finance, market entry, public services and the regulatory burden — the conditions that decide whether a 200-person factory can grow to 500.
Why a deep supplier base matters to buyers
A single capable factory is a single point of failure. A deep supplier base means that when one plant is full, a buyer can move to a second with comparable processes, and that component suppliers — valves, sieves, compressors, sensors — cluster close enough to shorten lead times.
It also changes the negotiating position. In a region with dozens of qualified manufacturers, a supplier cannot rely on being the only option, so specifications and documentation tend to be taken more seriously. In a region with two, the buyer absorbs the risk.
The caveat is that tier status is a starting filter, not a substitute for an audit. A national little giant designation confirms that a company holds a defensible position in one narrow market; it does not confirm that its medical gas pipeline welds pass your inspector, that its pressure vessels carry the certificate your country requires, or that the address on the certificate is the address that will build your order.
What the batch tells a buyer
For a distributor building a supplier list, the batch is a useful map: 95 companies added in one round, 202 in total, and a city that pays part of the cost of the next step. The practical move is to ask a candidate supplier which batch it entered, what it changed in its quality system as a result, and whether the certificate covers the address that will build your order — the answer tells you more than the certificate does.
Source: People’s Daily Sichuan Channel, 14 October 2022 — https://sc.people.com.cn/n2/2022/1014/c379471-40160053.html